|VASALGEL - RISUG - Scientific Papers On Drug Trials|

|VASALGEL - RISUG - Scientific Papers On Drug Trials|
|:------:|
|• Guha, Sujoy K., et al. "**[Phase I clinical trial of an injectable contraceptive for the male.](https://www.ncbi.nlm.nih.gov/pubmed/8222664)**" Contraception 48.4 (1993): 367-375. doi:10.1016/0010-7824(93)90082-I - [Full Pdf Copy](https://www.dropbox.com/s/x1wr5u21iz2b5cu/RISUG%20-%20Phase%20I%20clinical%20trial%20of%20an%20injectable%20contraceptive%20for%20the%20male%201993%20.pdf?dl=0)|
|• Guha, Sujoy K., et al. "**[Phase II clinical trial of a vas deferens injectable contraceptive for the male.](http://www.sciencedirect.com/science/article/pii/S001078249700142X)**" Contraception 56.4 (1997): 245-250. doi:10.1016/S0010-7824(97)00142-X - [Full Pdf Copy](https://www.dropbox.com/s/wiemchg9gld0dig/RISUG%20-%20Phase%20II%20clinical%20trial%20of%20a%20vas%20deferens%20injectable%20contraceptive%20for%20the%20male%201997.pdf?dl=0)|
|• Thakur, Vikas, et al. "**[RISUG: A new perspective in non–hormonal male contraception](http://www.sciencedirect.com/science/article/pii/S2305050013601384)**." Asian Pacific Journal of Reproduction 2.2 (2013): 159-162. doi:10.1016/S2305-0500(13)60138-4 - [Full Pdf Copy](http://www.sciencedirect.com/science/article/pii/S2305050013601384)|
|• Lohiya, N. K., et al. "**[RISUG: An intravasal injectable male contraceptive.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345756/)**" The Indian journal of medical research 140.Suppl 1 (2014): S63. PMCID: PMC4345756 - [Full Pdf Copy](http://www.sciencedirect.com/science/article/pii/S2305050013601384)|
|**Men and Their Partners Want Better Birth Control Options**. Male Contraception Initiative works with researchers across the globe to make male contraceptive options a reality. **https://www.malecontraceptive.org/**|
|**[Parsemus Foundation](https://www.parsemus.org/projects/vasalgel/)** - located in Berkeley, CA, is a small private foundation that was incorporated in 2005 and is registered as a 501(c)(3) nonprofit organization. Parsemus Foundation’s goal is to find low cost solutions that have been neglected by the pharmaceutical industry.|